The trial group wasn't you — start low
Dose ranges often come from heavier, less-active study groups. If you're leaner, the same dose hits harder.
Every dose range you read came from somewhere. Usually it's a clinical trial with a specific kind of person in it — a particular average weight, body composition, and activity level. That context gets quietly stripped off when the number travels from the paper to a forum post to your notes app, and it matters far more than almost anything else when you're deciding where to start. The dose isn't wrong. It just wasn't calibrated on you.
A dose is really a dose-per-body
The same milligrams behave differently in different bodies, because what actually matters biologically is closer to dose per unit of body mass than dose in absolute terms. A figure calibrated in a trial full of heavier, more sedentary participants represents a smaller dose-per-kilogram than the identical number does in a leaner, lighter, more active person. So when a lean reader takes the 'standard' starting dose lifted from a trial, they may be getting an effectively larger exposure than the trial subjects themselves ever experienced — and the side-effect profile tends to scale right along with it. The headline number stayed the same; the body it landed in did not.
The heart-rate example
There's a clean, concrete illustration of this buried in the development data for one multi-agonist. In the larger, heavier trial cohort, a low dose barely moved resting heart rate — a fraction of a beat per minute on average. In a leaner, earlier-phase group given the same low dose, the average rise was several times larger. Same milligrams, very different bodies, very different cardiovascular response. The lesson generalizes well beyond heart rate: 'well tolerated' in one population is a statement about that population, not a promise extended to you, and it can quietly understate what a smaller person will feel.
What to actually do about it
The conclusion isn't dramatic — it's just disciplined, and it's the same advice that experienced people give for almost everything in this space. If you're lighter or leaner than a typical trial participant, start at or below the bottom of the quoted range rather than at the 'standard' dose. Climb slowly, in small steps, and pay attention to the signals your body is actually giving you: resting heart rate, nausea, how you feel in the hours and days between doses. Titration isn't only about easing side effects; it's the process by which you find your dose instead of inheriting someone else's. And none of this is medical advice — it's a reason to be conservative and attentive, not a protocol to follow blindly.
Common questions
Starting at or below the low end of the range is the conservative move, especially if you're leaner than a typical trial participant. Climb from there based on response.
No. It's a case for being conservative and attentive. Anything you do is research and education and your own responsibility.
Resting heart rate, nausea and GI tolerance, and how you feel between doses are the practical, trackable ones.
For research and educational purposes only. Not medical advice.